HORIBA, a global leader in analytical and measurement technology, has expanded its award-winning compact hematology instrument range with the launch of new models with Erythrocyte Sedimentation Rate ...

No articles found. Horiba ABX SAS did not contribute to any primary research papers from Nature Index journals in the current 12 month window. The following affiliated institutions are wholly owned, ...

Yumizen H500 full blood count analyzer demonstrates exceptional correlation with larger laboratory-based systems HORIBA UK Ltd, Medical announces the publication of two studies successfully evaluating ...

HORIBA UK Ltd, Medical announces that HORIBA, Ltd. (Headquarters in Kyoto, Japan, referred to as HORIBA) and HORIBA Instruments (Headquarters in Irvine, California) has acquired MedTest Holdings, Inc.

Using its haematology expertise, the company has developed 'CoRA' (correlated rouleaux analysis) technology to integrate ESR into its three new analysers. Combining complete blood count (CBC) and ...

Japan’s Horiba Group has augmented its already broad portfolio of Raman imaging and spectroscopy technologies with a deal to acquire Salt Lake City’s Process Instruments. The acquisition is intended ...

HORIBA opens UK Analytical Solution Plaza to support science, tech and STEM outreach with advanced tools and global expertise. HORIBA Medical has launched the new HELO 2.0 high throughput automated ...

Horiba shares have declined due to a stronger Yen and market dislocation, but the market likely overreacted. Horiba's diversified segments and strong R&D investments position it well for future growth ...

Horiba is likely undervalued due to it being under followed, and offers a rare combination of a quality business at an attractive price. The company has high market share in specialized devices in ...

Investing.com -- HORIBA STEC KOREA, Ltd., a subsidiary of HORIBA, has completed the acquisition of EtaMax Co., Ltd., a South Korean company specializing in the development, manufacturing, and selling ...